Wardle E N, Menon I S, Rastogi S P
Br Med J. 1970 May 2;2(5704):260-3. doi: 10.1136/bmj.2.5704.260.
Plasma and urine fibrinolysis were studied in 36 patients with glomerulonephritis and proteinuria. In 40% of these plasma fibrinolytic activator activity was moderately reduced and fibrinolytic inhibitors were increased. Globulins with antiplasmin effect were raised, particularly in the earlier months. Both the serum cholesterol and the plasma fibrinogen were related to the level of serum albumin, and those patients with high fibrinogen levels were also those with poor plasma fibrinolytic activator and those showing a steady deterioration. Urinary fibrinolysis was greatly reduced in most patients and bore no relation to plasma fibrinolysis levels. Hence urokinase is not derived from circulating plasminogen activator.
对36例肾小球肾炎伴蛋白尿患者的血浆和尿液纤溶情况进行了研究。其中40%的患者血浆纤溶激活剂活性中度降低,纤溶抑制剂增加。具有抗纤溶酶作用的球蛋白升高,尤其是在最初几个月。血清胆固醇和血浆纤维蛋白原均与血清白蛋白水平有关,纤维蛋白原水平高的患者也是血浆纤溶激活剂水平低且病情呈持续恶化的患者。大多数患者的尿液纤溶作用大大降低,且与血浆纤溶水平无关。因此,尿激酶并非来源于循环中的纤溶酶原激活剂。